Commonwealth Biotechnologies, Inc. Announces $ 2.0 Million of New Business Contracts
Focus in Core Competency Areas
16-Aug-2004 -
Commonwealth Biotechnologies, Inc., is pleased to announce new contract work in two of its core business areas, bio-defense and clinical lab trial support. The new contracts total more nearly $2.0 million and are with government and private sector clients. CBI is continuing to build its ...
bases
clinical trials
genetic markers
+6